News/ UK & Europe/ US Novo’s Tresiba primed for key ‘hypo’ label update in EU Richard Staines Diabetes, Fiasp, Novo Nordisk, safety, Sanofi, Tresiba 0 Comment Fast-acting insulin also approved in US Share X Novo’s Tresiba primed for key ‘hypo’ label update in EU https://pharmaphorum.com/news/novos-tresiba-gets-key-hypo-label-update-eu/